• Trying to understand why some patients respond and others don’t, or why the CAR T cells remain durable for some and not for others;
  • Figuring out how to switch off the T cells when the immune response becomes dangerously strong in some patients; and
  • Identifying specific combinations of immunotherapies, or how to optimally combine them with chemotherapies or other targeted therapies to improve outcomes for certain subtypes of blood cancers
#ASH18

--

--

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
The Leukemia & Lymphoma Society

The Leukemia & Lymphoma Society

964 Followers

The Leukemia & Lymphoma Society (LLS) is dedicated to funding research, finding cures and ensuring access to treatments for blood cancer patients.